InvestorsHub Logo
Followers 14
Posts 818
Boards Moderated 1
Alias Born 11/13/2019

Re: None

Friday, 07/21/2023 7:50:32 AM

Friday, July 21, 2023 7:50:32 AM

Post# of 3894
$RDHL - Up 7.5% Pre-Market/ Current Price $2.02
Announces U.S. Government Funding for Opaganib Nuclear Countermeasure Development
Opaganib awarded a further $1.7m for development as a medical countermeasure for gastrointestinal acute radiation syndrome (ARS)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RDHL News